News | May 27, 2026
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
The company highlighted continued demand strength and pricing resilience despite global disruptions
The company highlighted continued demand strength and pricing resilience despite global disruptions
The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
